To authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Pennsylvania's 8th congressional district. Republican.
Last Updated: Mar 21, 2018
Length: 14 pages
H.R. 5247 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2018). H.R. 5247 — 115th Congress: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018. Retrieved from https://www.govtrack.us/congress/bills/115/hr5247
“H.R. 5247 — 115th Congress: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018.” www.GovTrack.us. 2018. March 24, 2018 <https://www.govtrack.us/congress/bills/115/hr5247>
|title=H.R. 5247 (115th)
|accessdate=March 24, 2018
|author=115th Congress (2018)
|date=March 13, 2018
|quote=Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.